DTC Healthcare with 23andMe CEO Anne Wojcicki
Motley Fool Money
Innovations in Drug Development Through Genetic Insights
This chapter explores a company's groundbreaking approach to drug development by utilizing genetic health data to identify new therapeutic possibilities. It details their journey from lab insights to successful collaborations with major pharmaceutical firms, all while addressing unmet medical needs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
